Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.
about
Condensation of oligonucleotides assembled into nicked and gapped duplexes: potential structures for oligonucleotide deliveryEnhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimersNanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery.The potential of antisense as a CNS therapeutic.Conjugation of poly(amidoamine) dendrimers with various acrylates for improved delivery of plasmid encoding interleukin-12 gene.Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.Generation 3 PAMAM dendrimer TAMRA conjugates containing precise dye/dendrimer ratiosDNA-based therapeutics and DNA delivery systems: a comprehensive review.Fluorophore:dendrimer ratio impacts cellular uptake and intracellular fluorescence lifetime.Antisense oligonucleotides: from design to therapeutic application.Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro.Whole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides.Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.Dendrimers for enhanced drug solubilization.Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactivesCarrier mediated protein and peptide stabilization.Integrin targeted delivery of gene therapeuticsFluorescence in nanobiotechnology: sophisticated fluorophores for novel applications.Design and development of antisense drugs.Nonviral gene delivery with dendritic self-assembling architectures.Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis.Dendritic nanoconjugates for intracellular delivery of neutral oligonucleotidesImproved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.Targeting Splicing in the Treatment of Human DiseaseIntracellular delivery of oligonucleotide conjugates and dendrimer complexes.Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity.Rational design of novel, fluorescent, tagged glutamic acid dendrimers with different terminal groups and in silico analysis of their properties.Increase in Dye:Dendrimer Ratio Decreases Cellular Uptake of Neutral Dendrimers in RAW Cells.Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications.Surface Hydrophobic Modification of Fifth-Generation Hydroxyl-Terminated Poly(amidoamine) Dendrimers and Its Effect on Biocompatibility and Rheology.Dendritic polymers for dermal drug delivery.Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.Telomerase - strategies to exploit an important chemotherapeutic target.Dendrimer-Based Gene Delivery Systems: Administration Routes andIn VivoEvaluationHyperbranched–dendrimer architectural copolymer gene delivery using hyperbranched PEI conjugated to poly(propyleneimine) dendrimers: synthesis, characterization, and evaluation of transfection efficiency
P2860
Q24793712-4B5C4D2B-56BB-4182-8160-FDA26074ECB1Q33201676-EF399638-865D-4804-A97D-B377FDB5304DQ33622573-1688087C-9364-4018-8C3B-1BAA267CA2BCQ34054137-4F5D24E5-8647-4801-93A9-6521DFF9C201Q35143897-6467C321-AB35-4B03-A9E5-BB1234F69F16Q35247054-F8C564EC-B769-49B9-913C-CFB965E888E5Q35823712-E452B8EB-3336-4571-B221-BA72185AC6C4Q36243772-CF7F3319-F1EA-43BF-915F-C2954F18D05EQ36250777-DBF4B545-45D5-459A-ACEB-6D691FD11E8CQ36257315-6B399142-F8E1-4D89-BAA8-09B33F6F79B5Q36478849-A57DC367-FB3D-4620-87B4-E7520938658EQ36649655-88664413-B9C8-4791-9B53-54476303C197Q36864315-4195349D-8642-440F-A32B-D545A6A303BDQ37114452-C9D96C36-E282-469E-9AA2-C0D1EE3DA6DDQ37122097-3A4D39B8-6026-4F26-9EE0-F4D9A6A97B73Q37193000-19FBC5C5-3E90-47E9-9967-D0E9A15F98F7Q37279284-44BE0775-A704-4FF7-A8DD-D23FDBC241F5Q37472758-82544988-8CC8-4D05-8B6D-77852F467AD7Q37794158-435A696C-564B-42C8-A3FB-51E73C8246E0Q37872613-CD4AEDBA-953A-4D47-A51A-73FC0633D7A1Q38017153-1ACB0557-FCF3-418A-A56F-76B21623668FQ38089175-3FDE12C6-37C1-4F31-9BD8-67AEBE7818E6Q38211725-451AC86B-A9E6-4010-98FC-CE90D0B1B516Q38264255-D682B88B-5116-4120-9764-84614DF47AA4Q38290306-6648D05F-A26D-41EE-B3D9-E9F7639FE2E9Q38857866-9A9AE2AB-AA85-4662-AED6-ED67FCE04332Q39021362-95945998-C1F9-4BEC-B5A2-63E8D664E579Q39154733-B266FA5F-3E62-427B-B86C-4A2BF7AE2C2AQ40200695-21C926D3-3159-4C25-88D2-319756ECEA21Q40203487-E8C9ABDF-D8FA-49F1-8B7E-35F41975BD27Q41907199-29CD370D-65E1-4DFF-ADFA-C2EB522583E7Q42283193-D110DAD9-BD2F-4937-9267-9084F23CBB58Q42317454-E0182691-B3BB-4E74-9DE9-6FA50CFF7A68Q46408569-D5A64E42-57FD-4A1C-BC21-07BFE0FD0446Q46728997-8F24760E-7C8F-4EDE-B718-7EA4C483ECD6Q50073512-1830A4DB-E4AD-4B12-8B05-050DFC1392EBQ51116307-86FCF899-DBB1-4864-8510-BF3CDBA168BCQ52549011-7320C98D-B5B2-4464-84F3-D9C0CCF302E6Q57610427-708E4EC2-4824-48A6-9ED4-8B4D242AFD78Q59202063-F68389CF-1734-4B6C-B0BA-8026C1A0233C
P2860
Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@en
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@nl
type
label
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@en
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@nl
prefLabel
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@en
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@nl
P2860
P356
P1476
Enhanced delivery of antisense ...... e-conjugated PAMAM dendrimers.
@en
P2093
P2860
P304
P356
10.1093/NAR/28.21.4225
P407
P577
2000-11-01T00:00:00Z